Health and Medical News Vertex Pharmaceuticals Inc on Thursday said a combination of its cystic fibrosis drug Kalydeco and an experimental compound was shown to improve lung function in a mid-stage trial, sending its shares up nearly 8 percent. The study found that trea...
by via @ Health and Medical News
by via @ Health and Medical News